Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
Intertrochanteric fractures are common injuries, particularly among the elderly population, necessitating effective surgical management for optimal outcomes. This study aimed to compare the efficacy, functional outcomes, and complications of two commonly employed surgical techniques: Proximal Femoral Nail (PFN) and its advanced iteration, Proximal Femoral Nail A2 (PFN A2), in the treatment of intertrochanteric fractures. A prospective comparative study was conducted from May 2022 to May 2023, involving 40 patients with intertrochanteric fractures who were randomly allocated into two groups: PFN (n=20) and PFN A2 (n=20). Parameters evaluated included radiological evidence, surgical variables, intraoperative parameters, achieved reduction, postoperative weight‐bearing duration, and complications. Functional outcomes were assessed using the Harris Hip Score (HHS) and Parker Palmer Mobility Score at 3 and 7 months follow‐up. Results: The mean patient age was 65.2 years in the PFN group and 68.5 years in the PFN A2 group. The PFN A2 group demonstrated a better mean Harris Hip Score at 3 months (69.31 vs. 65.32) and 7 months (80.24 vs. 77.72) follow‐up compared to the PFN group. The PFN A2 group also showed a higher Parker Palmer Mobility Score (7.4 vs. 7.1) and had reduced operative time (46.12 minutes vs. 52.2 minutes) and postoperative blood loss (0.3 gm% reduction vs. 0.5 gm%) compared to the PFN group. Both groups had a low incidence of complications, however, the PFN A2 group had fewer complications compared to the PFN group. The PFN A2 technique demonstrated superior functional outcomes, reduced operative time, and fewer complications compared to the traditional PFN method in the management of intertrochanteric fractures. These findings suggest that PFN A2 may offer improved anatomical restoration, better functional outcomes and fewer complications, making it a preferable choice for treating intertrochanteric fractures. However, further large‐scale studies are required to validate these findings and establish PFN A2 as the standard treatment for intertrochanteric fractures.
How to cite this article:
D.V. Mahesh and Alok Ashok Hinda. A Comparative Study of Management of Intertrochanteric Fracture with PFN vs PFN A2.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.6.1.5
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.6.1.5